Skip to main content
. 2003 Dec;56(6):328–335. doi: 10.1136/mp.56.6.328

Table 9.

Clinicopathological parameters in relation to p53 expression in the tumour

p53 expression p Value
<10% ⩾10%
Age (years)
    <50 28 11
    ⩾50 41 10 0.345
Menopausal
    Pre 24 10
    Post 43 11 0.338
T size
    T1 34 8
    T2 35 13 0.374
Grade
    1 16 1
    2 36 2
    3 17 18 0.001
p34cdc2TN
    <10% 13 1
    ⩾10% 56 20 0.122
p34cdc2TC
    <10% 24 3
    ⩾10% 44 16 0.107
p34cdc2bn
    <10% 46 13
    ⩾10% 10 2 0.683
p21WAF1
    <6% 32 13
    ⩾6% 37 8 0.217
ER
    Negative 18 17
    Positive 48 4 0.001
PR
    Negative 28 16
    Positive 40 5 0.005
Relapse
    No 58 21
    Yes 11 – 0.052
Death
    No 61 21
    Yes 8 – 0.104

ER, oestrogen receptor; p34cdc2bn, p34cdc2 expression in benign breast tissue; p34cdc2TC, p34cdc2 expression in tumour cytoplasm; p34cdc2TN, p34cdc2 expression in tumour nuclei; PR, progesterone receptor.